Group 8 PSA Genetic Engineering
By: nmadhaniprs
Follow this link:
Category Archives: Genetic Engineering
Genetic Engineering – Restriction Enzymes – Part 3 – Anytime Education – Video
Genetic Engineering - Restriction Enzymes - Part 3 - Anytime Education
http://www.anytimeeducation.com for more awesome free biology lessons. http://www.twitter.com/James_Dundon http://www.facebook.com/anytimeeducation Restriction enzymes, also known as ...
By: James Dundon
Read more here:
Genetic Engineering - Restriction Enzymes - Part 3 - Anytime Education - Video
New NASA and NSBRI report on sex and gender differences in adaptation to space flight
PUBLIC RELEASE DATE:
17-Nov-2014
Contact: Kathryn Ryan kryan@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News @LiebertOnline
New Rochelle, NY, November 17, 2014--In the future, as space exploration takes astronauts on longer missions and more female astronauts participate, "The Impact of Sex and Gender on Adaptation to Space" will become increasingly critical to astronaut safety and mission success, as explored in a special collection of articles published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The articles are available Open Access on the Journal of Women's Health website at http://online.liebertpub.com/toc/jwh/23/11.
In the Executive Summary, Drs. Saralyn Mark, Graham Scott, Dorit Donoviel, Lauren Leveton, John Charles, and Bette Siegel and Ms. Erin Mahoney from National Aeronautics and Space Administration (NASA), National Space Biomedical Research Institute (NSBRI), and Valador, Inc. provide an overview of six individual articles in the November issue of the Journal derived from the findings of workgroups formed to report on the current research related to sex- and gender-based differences in how humans adapt to spaceflight. Each workgroup and article focuses on a specific type of adaptation: cardiovascular, immunological, sensorimotor, musculoskeletal, reproductive, and behavioral.
In her Commentary, Dr. Mark remarks that in addition to ongoing missions for the purpose of space exploration and research, "NASA has promoted the development of the commercial space sector for the transport of payloads and eventually humans." The impact of sex and gender should influence "the development of equipment, machine-human interfaces, and countermeasures including the use of personalized medicine and genomics or -'astro-omics.'"
"Understanding sex and gender differences in physiological and psychological adaptation to space is increasingly important as the number of female astronauts increases," says Susan G. Kornstein, MD, Editor-in-Chief of Journal of Women's Health, Executive Director of the Virginia Commonwealth University Institute for Women's Health, Richmond, VA, and President of the Academy of Women's Health.
###
About the Journal
Journal of Women's Health, published monthly, is a core multidisciplinary journal dedicated to the diseases and conditions that hold greater risk for or are more prevalent among women, as well as diseases that present differently in women. The Journal covers the latest advances and clinical applications of new diagnostic procedures and therapeutic protocols for the prevention and management of women's healthcare issues. Complete tables of content and a sample issue may be viewed on the Journal of Women's Health website at http://www.liebertpub.com/jwh. Journal of Women's Health is the official journal of the Academy of Women's Health and the Society for Women's Health Research.
Originally posted here:
New NASA and NSBRI report on sex and gender differences in adaptation to space flight
Helping wheat defend itself against damaging viruses
Wheat diseases caused by a host of viruses that might include wheat streak mosaic, triticum mosaic, soil-borne mosaic and barley yellow dwarf could cost producers 5 to 10 percent or more in yield reductions per crop, but a major advance in developing broad disease-resistant wheat is on the horizon.
John Fellers, molecular biologist for the U.S. Department of Agriculture's Agricultural Research Service, and Harold Trick, plant geneticist for Kansas State University, have led an effort to develop a patent-pending genetic engineering technology that builds resistance to certain viruses in the wheat plant itself. And although genetically engineered wheat is not an option in the market today, their research is building this resistance in non-genetically engineered wheat lines as well.
"(Wheat viruses) are a serious problem," Trick said. "Wheat streak mosaic virus is one of the most devastating viruses we have. It's prevalent this year. In addition to that, we have several other diseases, triticum mosaic virus and soil-borne mosaic virus, that are serious diseases."
Knowing how costly these diseases can be for producers, Fellers has worked on finding solutions for resistance throughout his career. As a doctoral student at the University of Kentucky, he used a technology in his research called pathogen-derived resistance, or RNA-mediated resistance -- a process that requires putting a piece of a virus into a plant to make it resistant to that particular virus. Most of the viruses that infect wheat are RNA viruses, he said.
"The plant has its own biological defense system," Fellers said. "We were just triggering that with this technology."
Now Fellers, with the help of Trick, his wheat transformation facility and K-State graduate students, have developed transgenic wheat lines that contain small pieces of wheat streak mosaic virus and triticum mosaic virus RNA.
"It's kind of like forming a hairpin of RNA," Fellers said. "What happens is the plant recognizes this RNA isn't right, so it clips a piece of it and chops it up, but then it keeps a copy for itself. Then we have a resistance element."
Fellers compared the process to the old days of viewing most wanted posters on the post office wall. The piece of foreign RNA from the virus, which is a parasite, is one of those most wanted posters. Because the virus is a parasite, it has to seize or hijack part of the plant system to make proteins that it needs to replicate.
When the virus comes into the plant, the plant holds up that poster from the post office wall, recognizes the virus, and doesn't allow the virus to replicate and go through its lifecycle.
A broad resistance goal
See the article here:
Starbucks: Neil Young is wrong on boycott
Neil Young is swearing off Starbucks lattes.
NEW YORK (CNNMoney)
Last week, the singer said on his website, that he was kicking his daily Starbucks latte habit because he claimed the coffee company had teamed up with Monsanto to sue Vermont over a new law on genetically engineered foods. Young called out to his fans to join a petition by the organization SumOfUs.
Now both companies are denying that they are part of the lawsuit.
Starbucks (SBUX) flatly denied, via Twitter, that the company has anything to do with the lawsuit. Vermont's new labeling law requires that companies identify whether its food products contain genetically modified organisms.
"Starbucks is not a part of any lawsuit pertaining to GMO labeling nor have we provided funding for any campaign," said Starbucks. "And Starbucks is not aligned with Monsanto to stop food labeling or block Vermont State law. The petition claiming that Starbucks is part of this litigation is completely false and we have asked the petitioners to correct their description of our position."
Related: Starbucks CEO tells Congress 'stop the polarization'
Neither company is named in the lawsuit, but both are members of the Grocery Manufacturers Association, a lobbying group that filed the suit. But Starbucks said that doesn't matter.
"While we are a member of the GMA, we disagree with the association and Monsanto on this issue, and we don't support the lawsuit," the company said in an email to CNNMoney. "It is important for Starbucks to participate in trade associations because participation gives us a voice in the industry debate about these kinds of issues."
GMA spokesman Brian Kennedy confirmed that Starbucks is an "affiliate member" without any involvement in the group's lawsuit.
See the rest here:
Starbucks: Neil Young is wrong about boycott
Neil Young is swearing off Starbucks lattes.
NEW YORK (CNNMoney)
Last week, the singer said on his website, that he was kicking his daily Starbucks latte habit because he claimed the coffee company had teamed up with Monsanto to sue Vermont over a new law on genetically engineered foods. Young called out to his fans to join a petition by the organization SumOfUs.
Now both companies are denying that they are part of the lawsuit.
Starbucks (SBUX) flatly denied, via Twitter, that the company has anything to do with the lawsuit. Vermont's new labeling law requires that companies identify whether its food products contain genetically modified organisms.
"Starbucks is not a part of any lawsuit pertaining to GMO labeling nor have we provided funding for any campaign," said Starbucks. "And Starbucks is not aligned with Monsanto to stop food labeling or block Vermont State law. The petition claiming that Starbucks is part of this litigation is completely false and we have asked the petitioners to correct their description of our position."
Related: Starbucks CEO tells Congress 'stop the polarization'
Neither company is named in the lawsuit, but both are members of the Grocery Manufacturers Association, a lobbying group that filed the suit. But Starbucks said that doesn't matter.
"While we are a member of the GMA, we disagree with the association and Monsanto on this issue, and we don't support the lawsuit," the company said in an email to CNNMoney. "It is important for Starbucks to participate in trade associations because participation gives us a voice in the industry debate about these kinds of issues."
GMA spokesman Brian Kennedy confirmed that Starbucks is an "affiliate member" without any involvement in the group's lawsuit.
Read more here:
Will Genetic Engineering And Organ Growing Bring Us The Dawn Of The Superman? – Video
Will Genetic Engineering And Organ Growing Bring Us The Dawn Of The Superman?
The Fortean Slip Daily Dose 2 The Chris 2.0 Episode. In this episode Chris wonders if research into genetic engineering and organ growing will bring us the dawn of the superman. This webcast...
By: Fortean Slip
Continued here:
Will Genetic Engineering And Organ Growing Bring Us The Dawn Of The Superman? - Video
Modified DNA backbone enables success of existing and novel oligonucleotide therapeutics
PUBLIC RELEASE DATE:
13-Nov-2014
Contact: Kathryn Ryan kryan@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News @LiebertOnline
New Rochelle, NY, November 13, 2014--The two U.S. FDA approved oligonucleotide-based drugs on the market both have a modified chemical backbone made of phosphorothioates. The therapeutic advantages of the phosphorothioate group and the new types of gene expression-regulation oligonucleotide drugs that it is enabling are detailed in a Review article in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers. The article is available free on the Nucleic Acid Therapeutics website until December 13, 2014.
In the article "Phosphorothioates, Essential Components of Therapeutic Oligonucleotides," Fritz Eckstein, Max-Planck-Institut fr Experimentelle Medizin, Gttingen, Germany, describes how the chemical and biochemical properties of this significant nucleic acid modification have made DNA suitable for use as therapeutic agents. Initial applications focused on cleaving the mRNA product of genes to block protein production. Dr. Eckstein explores novel applications including microRNA and long non-coding RNA targets and the use of decoy oligonucleotides.
"We will advance the field of nucleic acid therapeutics by looking to key opinion leaders to educate and initiate the experienced and newcomers alike. In this review, Dr. Eckstein has produced a tour de force concerning the therapeutic application of phosphorothioates," says Executive Editor Graham C. Parker, PhD, The Carman and Ann Adams Department of Pediatrics, Wayne State University School of Medicine, Children's Hospital of Michigan, Detroit, MI.
###
Nucleic Acid Therapeutics is under the editorial leadership of Co-Editors-in-Chief Bruce A. Sullenger, PhD, Duke Translational Research Institute, Duke University Medical Center, Durham, NC, and C.A. Stein, MD, PhD, City of Hope National Medical Center, Duarte, CA; and Executive Editor Graham C. Parker, PhD.
About the Journal
Nucleic Acid Therapeutics is an authoritative, peer-reviewed journal published bimonthly in print and online that focuses on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. Nucleic Acid Therapeutics is the official journal of the Oligonucleotide Therapeutics Society. Complete tables of content and a sample issue may be viewed on the Nucleic Acid Therapeutics website.
More:
Modified DNA backbone enables success of existing and novel oligonucleotide therapeutics
Pinot Noir grapes owe a debt to ancient viruses
Next time you pour a glass of wine, raise a toast to the 30-million-year-old viruses that have contributed to the genetic make-up of modern grapes.
A team of UQ-led plant scientists has discovered that the Pinot Noir grape variety owes a significant part of its genetic heritage to ancient plant viruses.
In a study published in Nature Communications, Dr Andrew Geering and colleagues have mapped the presence of 30-million-year-old viruses in Pinot Noir DNA.
Viruses are usually a curse to farmers because of the damage they cause to crops, but this study also suggests they play a vital evolutionary role.
Dr Geering, a plant pathologist at the UQs Queensland Alliance for Agriculture and Food Innovation, said most flowering plant species, even the most primitive ones, contain sequence signatures of viruses in their genetic material.
Animals can move to avoid threats but because plants are anchored to the ground they are obliged to adapt to environmental pressures, such as those brought about by drought or grazing, using novel strategies.
Plants cope with such threats by acquiring new biochemical pathways or growth habits.
Pulling new genetic material from the environment, such as from viruses that infect the plant, means evolution can be sped up considerably.
Much like humans, plants are regularly exposed to harmful chemicals or radiation, which can cause damaging and heritable mutations to their genes which, if left unrepaired, could be lethal to their descendants.
Fortunately, there are special mechanisms to repair these mutations. Its during this repair procedure that foreign DNA such as that originating from viruses can be inserted into the plants own genetic code, much like using putty to fill a crack in the wall.
View post:
Zelig Eshhar and Carl H. June honored for research on T cell engineering for cancer immunotherapy
PUBLIC RELEASE DATE:
11-Nov-2014
Contact: Kathryn Ryan kryan@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News @LiebertOnline
New Rochelle, NY, November 11, 2014--Zelig Eshhar, PhD, The Weizmann Institute of Science and Sourasky Medical Center, and Carl H. June, MD, PhD, Perelman School of Medicine, University of Pennsylvania, are co-recipients of the Pioneer Award, recognized for lentiviral gene therapy clinical trials and for their leadership and contributions in engineering T-cells capable of targeting tumors with antibody-like specificity through the development of chimeric antigen receptors (CARs). Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers, is commemorating its 25th anniversary by bestowing this honor on the leading Pioneers in the field of cell and gene therapy selected by a blue ribbon panel* and publishing a Pioneer Perspective by the award recipients. The Perspectives by Dr. Eshhar and Dr. June are available free on the Human Gene Therapy website at http://www.liebertpub.com/hgt until December 11, 2014.
In his Pioneer Perspective entitled "From the Mouse Cage to Human Therapy: A Personal Perspective of the Emergence of T-bodies/Chimeric Antigen Receptor T Cells" Professor Eshhar chronicles his team's groundbreaking contributions to the development of the CAR T-cell immunotherapeutic approach to treating cancer. He describes the method's conceptual development including initial proof-of-concept, and the years of experimentation in mouse models of cancer. They first tested the CAR T-cells on tumors transplanted into mice then progressed to spontaneously developing cancers in immune-competent mice, which Dr. Eshhar describes as "a more suitable model that faithfully mimics cancer patients." He recounts successful antitumor effects in mice with CAR modified T-cells injected directly into tumors, with effects seen at the injection site and at sites of metastasis, and even the potential of the CAR T-cells to prevent tumor development.
Dr. Carl H. June has led one of the clinical groups that has taken the CAR therapeutic strategy from the laboratory to the patients' bedside, pioneering the use of CD19-specific CAR T-cells to treat patients with leukemia. In his Pioneer Perspective, "Toward Synthetic Biology with Engineered T Cells: A Long Journey Just Begun" Dr. June looks back on his long, multi-faceted career and describes how he combined his knowledge and research on immunology, cancer, and HIV to develop successful T-cell based immunotherapies. Among the lessons Dr. June has embraced throughout his career are to follow one's passions. He also says that "accidents can be good: embrace the unexpected results and follow up on these as they are often times more scientifically interesting than predictable responses from less imaginative experiments."
"These two extraordinary scientists made seminal contributions at key steps of the journey from bench to bedside for CAR T-cells," says James M. Wilson, MD, PhD, Editor-in-Chief of Human Gene Therapy, and Director of the Gene Therapy Program, Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia.
###
*The blue ribbon panel of leaders in cell and gene therapy, led by Chair Mary Collins, PhD, MRC Centre for Medical Molecular Virology, University College London selected the Pioneer Award recipients. The Award Selection Committee selected scientists that had devoted much of their careers to cell and gene therapy research and had made a seminal contribution to the field--defined as a basic science or clinical advance that greatly influenced progress in translational research.
About the Journal
Continue reading here:
Zelig Eshhar and Carl H. June honored for research on T cell engineering for cancer immunotherapy
Our wine owes a debt to ancient viruses
Next time you pour a glass of wine, raise a toast to the 30-milion-year-old viruses that have contributed to the genetic make-up of modern grapes.
A team of UQ-led plant scientists has discovered that the Pinot Noir grape variety owes a significant part of its genetic heritage to ancient plant viruses.
In a study published in Nature Communications, Dr Andrew Geering and colleagues have mapped the presence of 30-million-year-old viruses in Pinot Noir DNA.
Viruses are usually a curse to farmers because of the damage they cause to crops, but this study also suggests they play a vital evolutionary role.
Dr Geering, a plant pathologist at the UQs Queensland Alliance for Agriculture and Food Innovation, said most flowering plant species, even the most primitive ones, contain sequence signatures of viruses in their genetic material.
Animals can move to avoid threats but because plants are anchored to the ground they are obliged to adapt to environmental pressures, such as those brought about by drought or grazing, using novel strategies.
Plants cope with such threats by acquiring new biochemical pathways or growth habits.
Pulling new genetic material from the environment, such as from viruses that infect the plant, means evolution can be sped up considerably.
Much like humans, plants are regularly exposed to harmful chemicals or radiation, which can cause damaging and heritable mutations to their genes which, if left unrepaired, could be lethal to their descendants.
Fortunately, there are special mechanisms to repair these mutations. Its during this repair procedure that foreign DNA such as that originating from viruses can be inserted into the plants own genetic code, much like using putty to fill a crack in the wall.
Read the rest here:
OMD@MOL 1/11/2014 GENETIC ENGINEERING – Video
OMD@MOL 1/11/2014 GENETIC ENGINEERING
Don #39;t film and dance, and guess who mixed the lyrics up again?!!!!!
By: alan65
Go here to read the rest:
New approach helps women talk to their families about cancer risk
PUBLIC RELEASE DATE:
10-Nov-2014
Contact: Kathryn Ryan kryan@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News @LiebertOnline
New Rochelle, NY, November 10, 2014--To understand their risk for hereditary forms of cancer, such as breast and colon cancer, women need to know their family history. The design and effectiveness of a 20-minute skills-based intervention that can help women better communicate with relatives and gather and share information about cancer family history is described in a study in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Women's Health website at http://online.liebertpub.com/doi/full/10.1089/jwh.2014.4754 until December 10, 2014.
In the article "The KinFact Intervention - A Randomized Controlled Trial to Increase Family Communication About Cancer History," Joann Bodurtha, MD, and coauthors from Johns Hopkins University (Baltimore, MD), Virginia Commonwealth University (Richmond, VA), and Boston University (MA), describe the Keeping Information about Family Cancer Tune-up Program (KinFact) intervention.
KinFact participants were significantly more likely to gather and share family cancer information with relatives and to communicate with them more often than were women who instead received a handout about lowering cancer risk and cancer screening. The authors found that the effectiveness of KinFact varied depending on whether women were pregnant and on their level of genetic literacy.
"Communication within families about cancer diagnoses and risk is difficult, and interventions like KinFact are useful to better understand patients' family health risks," says Susan G. Kornstein, MD, Editor-in-Chief of Journal of Women's Health, Executive Director of the Virginia Commonwealth University Institute for Women's Health, Richmond, VA, and President of the Academy of Women's Health.
###
About the Journal
Journal of Women's Health, published monthly, is a core multidisciplinary journal dedicated to the diseases and conditions that hold greater risk for or are more prevalent among women, as well as diseases that present differently in women. The Journal covers the latest advances and clinical applications of new diagnostic procedures and therapeutic protocols for the prevention and management of women's healthcare issues. Complete tables of content and a sample issue may be viewed on the Journal of Women's Health website at http://www.liebertpub.com/jwh. Journal of Women's Health is the official journal of the Academy of Women's Health and the Society for Women's Health Research.
Read the original:
New approach helps women talk to their families about cancer risk
Can HIV be transmitted via manicure instruments?
PUBLIC RELEASE DATE:
10-Nov-2014
Contact: Kathryn Ryan kryan@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News @LiebertOnline
New Rochelle, NY, November 10, 2014--The Centers for Disease Control and Prevention (CDC) lists numerous potential alternative sources of HIV transmission in addition to the known classical modes for acquiring the AIDS virus. Although manicure instruments is not on this list of alternative sources, a case of HIV transmission that may be linked to sharing of manicure instruments is presented in AIDS Research and Human Retroviruses, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article appears in special issue on HIV Prevention Science and is available free on the AIDS Research and Human Retroviruses website at http://online.liebertpub.com/doi/full/10.1089/aid.2014.0264 until December 10, 2014.
In the article "An HIV-1 Transmission Case Possibly Associated with Manicure Care," Elaine Monteiro Matsuda and coauthors from Santo Andr AIDS Program, Adolfo Lutz Institute, and University of So Paulo, Brazil, describe the case of a 22-year-old woman who had advanced HIV infection but no apparent risk factors for acquiring HIV. She reported having shared manicure instruments years before with a cousin who was later found to be HIV-positive. Genetic analysis of the viruses from both patients suggests that they shared a common viral ancestor, indicating the possibility that HIV was transmitted via the manicure instruments.
"HIV is not transmitted by casual contact, such as sharing eating utensils, or drinking from the same water glass," says AIDS Research and Human Retroviruses Basic Sciences Editor/Sequence Notes Brian Foley, PhD, HIV Sequence Database, Los Alamos National Laboratory, NM. "This transmission of HIV by shared manicure equipment is a very rare event that should serve not to make people fear HIV or contact with HIV-infected people. It should make people aware that sharing any utensils with possible blood-blood contact, such as needles used for drugs, tattoos, or acupuncture can result in transmission of viruses such as hepatitis C (HCV) and HIV. In addition, there are other common viruses and bacteria that can also be spread by sharing equipment without proper disinfection between users."
###
About the Journal
AIDS Research and Human Retroviruses, published monthly in print and online, presents papers, reviews, and case studies documenting the latest developments and research advances in the molecular biology of HIV and SIV and innovative approaches to HIV vaccine and therapeutic drug research, including the development of antiretroviral agents and immune-restorative therapies. The content also explores the molecular and cellular basis of HIV pathogenesis and HIV/HTLV epidemiology. The Journal features rapid publication of emerging sequence information and reports on clinical trials of emerging HIV therapies. Tables of content and a sample issue may be viewed on the AIDS Research and Human Retroviruses website at http://www.liebertpub.com/aid.
About the Publisher
Follow this link:
Ebola = Genetic Engineering Financed by Pentagon? – Video
Ebola = Genetic Engineering Financed by Pentagon?
http://www.youtube.com/editor) This is straight from the Creative commons section You Tube provides.
By: MrGrimv1
Read this article:
Biodiversity of plant cell culture collections offers valuable source of natural insecticidal and fungicidal products
PUBLIC RELEASE DATE:
6-Nov-2014
Contact: Kathryn Ryan kryan@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News @LiebertOnline
IMAGE: Industrial Biotechnology, led by Co-Editors-in-Chief Larry Walker, PhD, Biological and Environmental Engineering Department, Cornell University, Ithaca, NY, and Glenn Nedwin, PhD, MoT, CEO and President, Taxon Biosciences, Tiburon, CA, is...
New Rochelle, NY, November 6, 2014Screening large cell culture collections containing plant samples obtained from diverse geographic regions, climates, and soil and growing conditions for biological activity can reveal a wealth of natural compounds with potential applications for crop improvement and protection. The capability to do reproducible screening and genomic analysis of the more than 2,000 plant cell lines maintained in culture at the Institute of Cell Biology and Genetic Engineering, in Kiev, Ukraine is describe in an article in Industrial Biotechnology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available on the Industrial Biotechnology website.
In the article "Screening Plant Biodiversity In Vitro for New Natural Products," Prof. Nikolay V. Kuchuk and coauthors from the Institute of Cell Biology and Genetic Engineering and Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, Kiev; Komarov Botanical Institute, Russian Academy of Sciences; Lawrence Berkeley National Laboratory, Berkeley, CA; and Hunter-Cevera & Associates, Ellicott City, MD, provide a detailed description of their methods for plant cell culture and the development of plant extracts for screening. The authors present the results of large-scale screening for insecticidal and fungicidal activity in 1,200 plant samples.
The article is part of the IB IN DEPTH special section entitled "Plants and Microorganisms: Moving Food and Agricultural Biotechnology Forward," led by Guest Editor Jennie Hunter-Cevera, PhD, Hunter-Cevera & Associates.
This issue of IB also features an Overview entitled "Exploring Plant-Microorganism Relationships for Natural Solutions to Sustainable Agriculture and Food Production," the Roundtable Discussion "Opportunities and Challenges for Plant Natural Product Research and Development," the Patent Update "Intellectual Property of Plants and Plant Products: Is Fruit Juice Eligible for Patent Protection?" and two Review articles: "Potential for Industrial Application of Microbes in Symbioses that Influence Plant Productivity and Sustainability in Agricultural, Natural, or Restored Ecosystems" and "Delayed Ripening of Climacteric Fruit by Catalysts Prepared from Induced Cells of Rhodococcus rhodochrous DAP 96253A Case for the Biological Modulation of Yang-Cycle Driven Processes by a Prokaryote."
"Leveraging the genetic diversity of the plant world is an important activity for agricultural, environmental, and industrial biotechnology sectors and is key to addressing a spectrum of global sustainability challenges," says Co-Editor-in-Chief Larry Walker, PhD, Professor, Biological & Environmental Engineering, Cornell University, Ithaca, NY.
###
Read the original here:
iOS android and windows phone Qvprep app Learn genetics and genetic engineering – Video
iOS android and windows phone Qvprep app Learn genetics and genetic engineering
This is our app title # 22 out of a total of 42 apps released till date. QVprep Genetic Engineering Covers * Introduction History of Genetic Engineering * ...
By: Deep Larry
Continue reading here:
iOS android and windows phone Qvprep app Learn genetics and genetic engineering - Video
6- Mutation & Genetic Engineering – Video
Free iOS, android, windows phone QVprep Lite Learn genetic engineering – Video
Free iOS, android, windows phone QVprep Lite Learn genetic engineering
This is our app title # 21 out of a total of 42 apps released till date. QVprep Lite Genetic Engineering is FREE and has limited content. The app gives you t...
By: Deep Larry
Continue reading here:
Free iOS, android, windows phone QVprep Lite Learn genetic engineering - Video
Dodo Bird 3D Scan Reveals Previously Unknown Bones
New laser scans of the dodo, perhaps the most famous animal to have gone extinct in human history, have unexpectedly exposed portions of its anatomy unknown to science, which are revealing secrets about how the bird once lived.
The dodo was a flightless bird about 3 feet (1 meter) tall that was native to the island of Mauritius in the Indian Ocean. It went extinct by 1693, less than a century after the Dutch discovered the island in 1598, killed off by creatures such as rats and pigs, which sailors introduced to Mauritius either accidentally or intentionally.
The giant bird was actually a type of pigeon. "The skull of the dodo is so large and its beak so robust that it is easy to understand that the earliest naturalists thought it was related to vultures and other birds of prey, rather than the pigeon family," said study co-author Hanneke Meijer at the Catalan Institute of Paleontology in Spain.
Surprisingly, despite the dodo's fame, and the fact the bird was alive during recorded human history, little is known about the anatomy and biology of this animal. "The dodo's extinction happened at a time when people didn't understand the concept of extinction science as we know it was still in its infancy,"lead study author Leon Claessens, a vertebrate paleontologist at the College of the Holy Cross in Worcester, Massachusetts, told Live Science. "This meant that nobody tried to make a collection of the bird or study it in detail." [Wipe Out! History's 7 Most Mysterious Extinctions]
To shed new light on the dodo, Claessens and his colleagues went to the Natural History Museum in Port Louis, Mauritius, to investigate the only known complete skeleton from a single dodo. All other dodo skeletons are composites of several birds.
Amateur naturalist and barber Etienne Thirioux found the specimen the researchers analyzed near Le Pouce Mountain on Mauritius in about 1903. It was unstudied by scientists until now.
The scientists used a laser scanner to create a 3D digital model of the specimen. In addition, they scanned a second dodo skeleton Thirioux also created, a composite of two or more skeletons that was housed at the Durban Museum of Natural Science in South Africa.
"We discovered that the anatomy of the dodo we were looking at was not previously described in detail," Claessens said. "There were bones of the dodo that were just unknown to science until now."